302 related articles for article (PubMed ID: 22041510)
1. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.
Genevay M; Mino-Kenudson M; Yaeger K; Konstantinidis IT; Ferrone CR; Thayer S; Castillo CF; Sahani D; Bounds B; Forcione D; Brugge WR; Pitman MB
Ann Surg; 2011 Dec; 254(6):977-83. PubMed ID: 22041510
[TBL] [Abstract][Full Text] [Related]
2. High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than "positive" cytology.
Pitman MB; Genevay M; Yaeger K; Chebib I; Turner BG; Mino-Kenudson M; Brugge WR
Cancer Cytopathol; 2010 Dec; 118(6):434-40. PubMed ID: 20931638
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
4. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
5. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
Smith AL; Abdul-Karim FW; Goyal A
Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
[TBL] [Abstract][Full Text] [Related]
6. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
7. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
8. Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms.
Ono J; Yaeger KA; Genevay M; Mino-Kenudson M; Brugge WR; Pitman MB
Cytojournal; 2011; 8():21. PubMed ID: 22145009
[TBL] [Abstract][Full Text] [Related]
9. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
10. Cytological and cyst fluid analysis of small (< or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions.
Pitman MB; Michaels PJ; Deshpande V; Brugge WR; Bounds BC
Pancreatology; 2008; 8(3):277-84. PubMed ID: 18497541
[TBL] [Abstract][Full Text] [Related]
11. Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms.
Pitman MB; Centeno BA; Daglilar ES; Brugge WR; Mino-Kenudson M
Cancer Cytopathol; 2014 Jan; 122(1):40-7. PubMed ID: 23939829
[TBL] [Abstract][Full Text] [Related]
12. Risk of malignancy in pancreatic cysts with cytology of high-grade epithelial atypia.
Hoda RS; Lu R; Arpin RN; Rosenbaum MW; Pitman MB
Cancer Cytopathol; 2018 Sep; 126(9):773-781. PubMed ID: 30257067
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
14. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.
Hwang DW; Jang JY; Lim CS; Lee SE; Yoon YS; Ahn YJ; Han HS; Kim SW; Kim SG; Yun YK; Han SS; Park SJ; Lim TJ; Kang KJ; Sim MS; Choi SH; Heo JS; Choi DW; Hur KY; Lee DS; Yun SS; Kim HJ; Cho CK; Kim HJ; Yu HC; Cho BH; Song IS
J Korean Med Sci; 2011 Jun; 26(6):740-6. PubMed ID: 21655058
[TBL] [Abstract][Full Text] [Related]
15. Cystic lesions and intraductal neoplasms of the pancreas.
Fasanella KE; McGrath K
Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
[TBL] [Abstract][Full Text] [Related]
16. Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.
Tsumura A; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2021 Feb; 169(2):388-395. PubMed ID: 32859391
[TBL] [Abstract][Full Text] [Related]
17. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
20. Imaging morphological changes of intraductal papillary mucinous neoplasm of the pancreas was associated with its malignant transformation but not with development of pancreatic ductal adenocarcinoma.
Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
Pancreatology; 2015; 15(6):654-60. PubMed ID: 26433405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
